Coronavirus Disease-2019 in Heart Transplant Recipients in Southeastern Michigan: A Case Series



      Since coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China, in December 2019, the number of cases has risen exponentially. Clinical characteristics and outcomes among patients with orthotopic heart transplant (OHT) with COVID-19 remain poorly described.


      We performed a retrospective case series of patients with OHT with COVID-19 admitted to 1 of 2 hospitals in Southeastern Michigan between March 21 and April 22, 2020. Clinical data were obtained through review of the electronic medical record. Final date of follow-up was May 7, 2020. Demographic, clinical, laboratory, radiologic, treatment, and mortality data were collected and analyzed.


      We identified 13 patients with OHT admitted with COVID-19. The mean age of patients was 61 ± 12 years, 100% were black males, and symptoms began 6 ± 4 days before admission. The most common symptoms included subjective fever (92%), shortness of breath (85%), and cough (77%). Six patients (46%) required admission to the intensive care unit. Two patients (15%) died during hospitalization.


      Black men may be at increased risk for COVID-19 among patients with OHT. Presenting signs and symptoms in this cohort are similar to those in the general population. Elevated inflammatory markers on presentation appear to be associated with more severe illness.

      Key Words

      To read this article in full you will need to make a payment


      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Li F.
        • Cai J.
        • Dong N.
        First cases of COVID-19 in heart transplantation from China.
        J Heart Lung Transplant. 2020; 39: 496-497
      1. Why black Americans are at higher risk for coronavirus - CNN [Internet]. Available at: Accessed April 12, 2020.

      2. Black people are dying of COVID-19 at alarming rates. Here's why. | HuffPost [Internet]. Available at: Accessed April 12, 2020.

        • Williams S.F.
        African Americans, hypertension and the renin angiotensin system.
        World J Cardiol. 2014; 6: 878
        • Vaduganathan M.
        • Vardeny O.
        • Michel T.
        • McMurray JJ V.
        • Pfeffer M.A.
        • Solomon S.D.
        Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19.
        N Engl J Med. 2020; 382: 1653-1659
        • Jin X.
        • Lian J.-S.
        • Hu J.-H.
        • Gao J.
        • Zheng L.
        • Zhang Y.-M.
        • et al.
        Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.
        Gut. 2020; 69: 1002-1009
        • Huang C.
        • Wang Y.
        • Li X.
        • Ren L.
        • Zhao J.
        • Hu Y.
        • et al.
        Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
        Lancet. 2020; 395: 497-506
        • Zhou F.
        • Yu T.
        • Du R.
        • Fan G.
        • Liu Y.
        • Liu Z.
        • et al.
        Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
        Lancet. 2020; 395: 1054-1062
        • Shi S.
        • Qin M.
        • Shen B.
        • Cai Y.
        • Liu T.
        • Yang F.
        • et al.
        Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.
        JAMA Cardiol. 2020 Apr 14; ([Epub ahead of print])
        • Akalin E.
        • Azzi Y.
        • Bartash R.
        • Seethamraju H.
        • Parides M.
        • Hemmige V.
        • et al.
        Covid-19 and kidney transplantation.
        N Engl J Med. 2020 Apr 24; ([Epub ahead of print])
        • Ruan Q.
        • Yang K.
        • Wang W.
        • Jiang L.
        • Song J.
        Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
        Intensive Care Med. 46. 2020: 846-848